Table. 3 Univariable and multivariable analyses of risk factors associated with receipt of bilateral mastectomy among women who were diagnosed with operable breast cancer and underwent germline genetic testing for hereditary breast and ovarian cancer (HBOC)

From: Impact of telehealth genetic counseling on contralateral prophylactic mastectomy rates among multi-ethnic breast cancer patients

 

Univariable logistic regression

 

Multivariable logistic regression

 

Characteristic

Univariable OR (95% CI)

P-value

Multivariable OR (95% CI)

P-value

Age at diagnosis, years

    

 <40

10.35 (6.23, 17.18)

<0.001

10.39 (5.92, 18.23)

<0.001

 40–49

4.47 (2.83, 7.05)

<0.001

5.09 (3.08, 8.42)

<0.001

 50–59

3.87 (2.35, 6.36)

<0.001

4.24 (2.48, 7.26)

<0.001

 > = 60

Reference

 

Reference

 

Genetic counseling type

    

 In-person

Reference

 

Reference

 

 Telehealth

1.34 (0.79, 2.24)

0.276

1.35 (0.72, 2.54)

0.353

 Oncologist-Led

0.51 (0.36, 0.73)

<0.001

0.87 (0.58, 1.31)

0.502

Race or ethnicity

    

 Non-Hispanic White

Reference

 

Reference

 

 Non-Hispanic Black

1.04 (0.67, 1.61)

0.861

0.98 (0.60, 1.60)

0.928

 Hispanic

1.14 (0.83, 1.58)

0.421

1.31 (0.91, 1.90)

0.152

 Asian

0.89 (0.55, 1.43)

0.618

0.89 (0.53, 1.52)

0.679

 Other or Unknown

0.69 (0.41, 1.19)

0.181

1.02 (0.55, 1.90)

0.940

Marital status

    

 Married

1.04 (0.79. 1.36)

0.792

Not in multivariable model

 

 Unmarried

Reference

   

 Unknown

1.30 (0.63, 2.67)

0.478

  

Stage

    

 0

1.09 (0.68, 1.75)

0.716

0.96 (0.57, 1.61)

0.872

 I

Reference

 

Reference

 

 II

1.79 (1.32, 2.44)

<0.001

1.35 (0.95, 1.91)

0.095

 III

1.68 (1.07, 2.65)

0.025

1.16 (0.69, 1.94)

0.568

Family history of breast cancer

    

 Yes

1.16 (0.89, 1.52)

0.280

1.30 (0.95, 1.77)

0.097

 No

Reference

 

Reference

 

Tumor hormone receptor-positive

    

 Yes

0.48 (0.35, 0.65)

<0.001

0.59 (0.41, 0.83)

0.003

 No

Reference

 

Reference

 

Genetic testing result

    

 P/LP

5.62 (3.81, 8.29)

<0.001

4.70 (3.03, 7.29)

<0.001

 VUS

1.03 (0.72, 1.47)

0.869

0.90 (0.61, 1.34)

0.599

 B/LB

Reference

 

Reference

 
  1. P-value < 0.05 were bolded and considered as statistically significant. Patients with unknown genetic counseling type, stage, tumor hormone receptor positivity were included in logistic regression analysis; however, results are not shown here due to very small numbers.
  2. P/LP pathogenic or likely pathogenic, B/LB benign or likely benign, VUS variants of uncertain significance, OR odds ratio, CI confidence interval.